OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE β-LACTAMASE INHIBITOR, ANTIBIOTIC AND β-LACTAM 'ENHANCER'
About the Authors
A. .. Morinaka
Meiji Seika Pharma Co., Ltd
Russian Federation
Russian Federation
Y. .. Tsutsumi
Russian Federation
M. .. Yamada
Russian Federation
K. .. Suzuki
Russian Federation
T. .. Watanabe
Russian Federation
T. .. Abe
Russian Federation
T. .. Furuuchi
Russian Federation
S. .. Inamura
Russian Federation
Y. .. Sakamaki
Russian Federation
N. .. Mitsuhashi
Russian Federation
T. .. Ida
Russian Federation
D. M. Livermore
Russian Federation
Review
For citations:
Morinaka A., Tsutsumi Y., Yamada M., Suzuki K., Watanabe T., Abe T., Furuuchi T., Inamura S., Sakamaki Y., Mitsuhashi N., Ida T., Livermore DM. OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE β-LACTAMASE INHIBITOR, ANTIBIOTIC AND β-LACTAM 'ENHANCER'. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2015;60(11-12):51-52. (In Russ.)
Views:
360
Email this article 